Source: ACS Pharmacology & Translational Science. Unidades: FCF, ICB
Subjects: LEUCEMIA MIELOIDE, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIRANDA, Lívia Bassani Lins De et al. Screening for antileukemia agents in FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukemia cells. ACS Pharmacology & Translational Science, v. 8, n. 8, p. 2756-2766, 2025Tradução . . Disponível em: https://dx.doi.org/10.1021/acsptsci.5c00317. Acesso em: 09 out. 2025.APA
Miranda, L. B. L. D., Ferraz, W. R., Lima, K., Carlos, J. A. E. G., Gatti, F. de M., Alves, R. H., et al. (2025). Screening for antileukemia agents in FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukemia cells. ACS Pharmacology & Translational Science, 8( 8), 2756-2766. doi:10.1021/acsptsci.5c00317NLM
Miranda LBLD, Ferraz WR, Lima K, Carlos JAEG, Gatti F de M, Alves RH, Trossini GHG, Machado Neto JA. Screening for antileukemia agents in FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukemia cells [Internet]. ACS Pharmacology & Translational Science. 2025 ; 8( 8): 2756-2766.[citado 2025 out. 09 ] Available from: https://dx.doi.org/10.1021/acsptsci.5c00317Vancouver
Miranda LBLD, Ferraz WR, Lima K, Carlos JAEG, Gatti F de M, Alves RH, Trossini GHG, Machado Neto JA. Screening for antileukemia agents in FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukemia cells [Internet]. ACS Pharmacology & Translational Science. 2025 ; 8( 8): 2756-2766.[citado 2025 out. 09 ] Available from: https://dx.doi.org/10.1021/acsptsci.5c00317